Comparison of integrated Chinese and Western medicine with and without somatostatin supplement in the treatment of severe acute pancreatitis

World Journal of Gastroenterology

Volumn 11, Issue 7, 2005, Pages 1073-1076

  Xia, Qing ^a   Yuan, Lin ^a   Yang, Xiao Nan ^a   Tang, Wen Fu ^a   Jiang, Jun Ming ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

APACHE II; Balthazar CT; C reaction protein level; Severe acute pancreatitis; Somatostatin supplement

Indexed keywords

BUPLEURUM ROOT; C REACTIVE PROTEIN; CHINESE DRUG; GENTIANA EXTRACT; HISTAMINE H2 RECEPTOR ANTAGONIST; SOMATOSTATIN; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; CHINESE MEDICINE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GENTIAN; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEPTICEMIA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TRADITIONAL MEDICINE;

EID: 14844335670     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i7.1073     Document Type: Article

References (13)

1. Liu XB, Jiang JM, Huang ZW, Tian BL, Hu WM, Xia Q, Chen GY, Li QS, Yuan CX, Luo CX, Yan LN, Zhang ZD. Clinical study on the treatment of severe acute pancreatitis by integrated traditional Chinese medicine and Western medicine. Sichuan Daxue Xuebao Yixueban 2004; 35: 204-208
2. Knaus WA, Zimmerman JE, Wagner DP, Draper EA, Lawrence DE. APACHE - acute physiology and chronic health evaluation: A physiologically based classification system. Crit Care Med 1981; 9: 591-597
3. The pancreatic surgery academic group of Chinese Medical association surgical branch. Clinical diagnosis of acute pancreatitis and criteria for grading. Zhonghua Waike Zazhi 1997; 35: 773-775
4. Balthazar EJ, Ranson JH, Naidich DP, Megibow AJ, Caccavale R, Cooper MM. Acute pancreatitis: Prognostic value of CT. Radiology 1985; 156: 767-772
5. Zhu LY, Gao FZ. Severe acute pancreatitis and multiple organ dysfunction syndrome. Linchuang Waike Zazhi 1998; 6: 124-125
6. Xia Q, Jiang JM, Gong X, Chen GY, Li L, Huang ZW. Experimental study of "Tong Xia" purgative method in ameliorating lung injury in acute necrotizing pancreatitis. World J Gastroenterol 2000; 6: 115-118
7. Jia PH, Zhang ZD, Zhou ZG, Jiang JM. Impact of WPY on pancreatic microcirculation of acute pancreatitis in mice. Huaxi Yida Xuebao 2001; 32: 92-95
8. Wu CT, Li ZL, Huang XC, Zhang ZL. Effect of Chinese medicine "Qing YiTang" and bifidobacterium mixture on intestinal bacterial translocation following acute necrotizing pancreatitis. Shijie Huaren Xiaohua Zazhi 1999; 7: 525-528
9. Dervenis C, Bassi C. Evidence-based assessment of severity and management of acute pancreatitis. Br J Surg 2000; 87: 257-258
10. Muller C, Uhl W, Gloor B, Worni M, Roggo A, Borgstrom A, Buchler MW. Acute pancreatitis-clinical and technical laboratory diagnostic and prognostic assessment. Swiss Surg 2000; 6: 235-240
11. Planas M, Perez A, Iglesia R, Porta I, Masclans JR, Bermejo B. Severe acute pancreatitis: Treatment with somatostatin. Intensive Care Med 1998; 24: 37-39
12. Paran H, Mayo A, Paran D, Neufeld D, Shwartz I, Zissin R, Singer P, Kaplan O, Skornik Y, Freund U. Octreotide treatment in patients with severe acute pancreatitis. Dig Dis Sci 2000; 45: 2247-2251
13. Andriulli A, Leandro G, Clemente R, Festa V, Caruso N, Annese V, Lezzi G, Lichino E, Bruno F, Perri F. Meta-analysis of somatostatin, octreotide and gabexate mesilate in the therapy of acute pancreatitis. Aliment Pharmacol Ther 1998; 12: 237-245